Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

InspireMD, Inc. Director's Dealing 2023

Apr 4, 2023

34187_dirs_2023-04-04_74e454fb-be5b-45cb-9a7e-1c26fda4aa67.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: InspireMD, Inc. (NSPR)
CIK: 0001433607
Period of Report: 2023-04-01

Reporting Person: BERMAN MICHAEL (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2023-04-01 Common Stock A 9491 Acquired 42827 Direct

Footnotes

F1: The shares of common stock reported in this row represent shares of restricted stock that are earned and vested upon grant and are issued in lieu of cash compensation in connection with the Reporting Person's service on the Issuer's Board of Directors for the quarter ended March 31, 2023.